Formulation and evaluation of antihyperglycemic leaf extracts of Zizyphus spina-christi (L.) WILLD

Pharmazie

Volumn 64, Issue 2, 2009, Pages 104-109

  Nesseem, Demiana I ^a   Michel, C G ^b   Sleem, A A ^c   El Alfy, T S ^b  

^a NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; ANTIDIABETIC AGENT; ASCORBIC ACID; BUTANOL; CETOMACROGOL; GELATIN; GLIMEPIRIDE; GLUCOSE; MACROGOL 400; MACROGOL 6000; METFORMIN; PETROLEUM ETHER; PLANT EXTRACT; SAPONIN; UNCLASSIFIED DRUG; ZIZYPHUS SPINA CHRISTI EXTRACT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CHRISTININ A; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICINAL PLANT; MOUSE; NONHUMAN; PLANT LEAF; RAT; ZIZYPHUS SPINA CHRISTI; ANIMAL; CALIBRATION; CHEMISTRY; DRUG EFFECT; JUJUBE; LIPID METABOLISM; LIVER FUNCTION TEST; METABOLISM; MICROCAPSULE; ORAL DRUG ADMINISTRATION; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; STANDARD; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CALIBRATION; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; LIVER FUNCTION TESTS; MICE; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; ZIZIPHUS;

EID: 65349085537     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8614     Document Type: Article

References (13)

1. Abdel-Zaher AD, Salim SY, Assaf MH, Abdel-Hady RH (2005) Antidiabetic activity and toxicity of Zizyphus spina-Christi leaves. J Ethnopharmacol 101: 129-138.
2. Amemiya T, Mizuno S, Hayashi Y (1998a) Development of emulsion type new vehicle for soft gelatin capsule. Selection of surfactant for development of new vehicle and its physicochemical properties. Chem Pharm Bull 46: 309-313.
3. Amemiya T, Mizuno S, Hayashi Y (1999) Absorption of vitamin K2 dogs after oral administration of a soft gelatin capsule formulation containing a new emulsion type vehicle. J Pharm Pharm 51: 1375-1380.
4. Allain CG, Poon LS, Chan CSG, Richmond WY, Fu PG (1974) Determination of blood cholesterol by enzymatic method. Clin Chem 20: 470.
5. Bateman NE, Uccellini DA (1984) Effect of formulation on the bioavailability of retinol, D-α-tocopherol and riboflavin. J Pharm Pharm 36: 461-464.
6. Eliasson SG, Samet JM (1969) Alloxan induced neuropathies lipid change in nerve and root fragments. Life Sci 81: 493-498.
7. Evans RJ (1968) Determination of blood urea. J Clin Path 21: 527.
8. Ghirardi P, Catenazzo G, Mantero O, Meroti GC (1977) Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules. J Pharm Sci 66: 267-269.
9. Glombitza KW, Mahran GH, Mirhom YM, Michel CG, Motawi TK (1994) Hypoglycemic and antihyperglycemic effects of Zizyphus spina-Christi in rats. Planta Med 60: 244-247.
10. th ed., W.B. Saunders Co. Philadelphia.
11. Karber G (1931) Determination of LD50. Arch Exp Pathol Pharmacol 162: 480.
12. Lesko LJ, Canada AT, Eastwood G (1979) Pharmacokinetics and relative bioavailability of oral theophylline capsules J Pharm Sci 68: 1392-1494.
13. Mahran GH, Glombitza KW, Mirhom YW, Hartmann R, Michel CG (1996) Novel saponins of Zizyphus spina-christi (L.) Willd cultivated in Egypt. Plant Med 62: 163-165.